Compare ROL & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ROL | CNC |
|---|---|---|
| Founded | 1948 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5B | 21.5B |
| IPO Year | 1994 | 2001 |
| Metric | ROL | CNC |
|---|---|---|
| Price | $52.54 | $32.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 17 |
| Target Price | ★ $66.10 | $41.94 |
| AVG Volume (30 Days) | 2.4M | ★ 5.6M |
| Earning Date | 04-22-2026 | 04-24-2026 |
| Dividend Yield | ★ 1.38% | N/A |
| EPS Growth | ★ 13.54 | N/A |
| EPS | ★ 1.09 | N/A |
| Revenue | $2,161,220,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $10.42 | $8.29 |
| Revenue Next Year | $8.81 | $1.26 |
| P/E Ratio | $48.51 | ★ N/A |
| Revenue Growth | 7.23 | ★ 19.44 |
| 52 Week Low | $51.77 | $25.08 |
| 52 Week High | $66.14 | $66.03 |
| Indicator | ROL | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 26.74 | 29.50 |
| Support Level | N/A | $25.08 |
| Resistance Level | $58.38 | $33.44 |
| Average True Range (ATR) | 1.21 | 1.51 |
| MACD | -0.14 | -0.36 |
| Stochastic Oscillator | 4.13 | 2.77 |
Rollins is a global leader in route-based pest control services, with operations primarily in the United States and across North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US and Canada, with near-national coverage. It also has a portfolio of other brands, which it uses to reach customers through alternative sales channels. Residential pest and termite prevention accounts for the majority of Rollins' services, reflecting its ongoing focus on the US and Canadian markets.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.